Clinical Case Scenarios: Approaches to Treatment Decisions in Non-Small Cell Lung Cancer
Updates and Advances in Esophageal Squamous Cell Carcinoma (ESCC)
Updates in the Management of Small-Cell Lung Cancer in the Second-Line and Beyond
Evidence-based Management of Breast Cancer: Updates From SABCS
Recent Updates in Molecular Targets and Pathways in Lung Cancer
Sponsored by Daiichi Sankyo. Content independently developed by OncLive®.
Uncommon Mutations in NSCLC
Best Practices on Addressing Disparities and Practicing Multicultural Care in Myeloma
Exploring Recent Updates in the Treatment of Breast Cancer
Advances in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Best Practices for Managing Tyrosine Kinase Inhibitor-Related Adverse Events
Exploring the Role of Antibody Drug Conjugates in Non-Small Cell Lung Cancer
Best Practices Along the Tissue Journey in NSCLC
The Evolving Treatment Landscape in Relapsed/Refractory Follicular Lymphoma
Clinical Scenarios: Treatment Decisions in Non-Small Cell Lung Cancer
Practical Approaches to Treatment in Breast Cancer
Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer
Exploring Recent Developments in the Treatment of Patients with HR+ Metastatic Breast Cancer
Bruton Tyrosine Kinase (BTK) Inhibitors in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Practical Approaches to Treatment in Patients with Breast Cancer
Clinical Scenarios: Treating Patients with Gastric Cancer
Multidisciplinary Management of Patients with Basal Cell Carcinoma
New Directions in CLL
Treatment Decisions in Non-Small Cell Lung Cancer
Evolving Approaches in the Treatment of AML and MDS
Sponsored in part by Servier Pharmaceuticals. Content independently developed by OncLive.
HER2 Biomarker Testing in Breast and Gastrointestinal Cancers: The Role of the Pathologist
Funding from Daiichi Sankyo; Content Developed Independently by OncLive.
Current and Emerging Trends in Breast Cancer: HER2+ and HER2-Low
Treatment Updates and Advances in Cervical Cancer
Current and Emerging Trends in Breast Cancer: HER2 + and HER2-Low: An OncLive® Scientific Interchange and Workshop
Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive®
Current and Future Trends in Myelofibrosis: Cytopenias
Community Perspectives in Non-Small Cell Lung Cancer
Dr Caimi on Early Data for LMY-920 in R/R B-Cell NHL
Navigating a “Sea Change” in Frontline Urothelial Carcinoma Treatment
Dr Scalici on Data for IMNN-001 Plus SOC Chemotherapy in Advanced Ovarian Cancer
Dr Lin on the Safety of NKTR-255 in Enhancing Immune Recovery Post-Chemoradiation in Locally Advanced NSCLC
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
